Comparison of Human Insulin Produced by the Current Process and the NN729 Process in Type 1 Diabetes

PHASE3CompletedINTERVENTIONAL
Enrollment

241

Participants

Timeline

Start Date

May 1, 2003

Primary Completion Date

January 19, 2004

Study Completion Date

January 19, 2004

Conditions
DiabetesDiabetes Mellitus, Type 1
Interventions
DRUG

human insulin

Trial Locations (15)

1200

Novo Nordisk Investigational Site, Makati City

1800

Novo Nordisk Investigational Site, Marikina City

2228

Novo Nordisk Investigational Site, Miranda

2292

Novo Nordisk Investigational Site, Broadmeadow

4021

Novo Nordisk Investigational Site, Kippa-Ring

4120

Novo Nordisk Investigational Site, Stones Corner

5035

Novo Nordisk Investigational Site, Keswick

6000

Novo Nordisk Investigational Site, Cebu City

10450

Novo Nordisk Investigational Site, Georgetown, Penang

16150

Novo Nordisk Investigational Site, Kota Bharu, Kelantan

56000

Novo Nordisk Investigational Site, Cheras

NZ

Novo Nordisk Investigational Site, Dunedin

Novo Nordisk Investigational Site, Hamilton

Unknown

Novo Nordisk Investigational Site, Shatin, New Territories

Novo Nordisk Investigational Site, Iloilo City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Novo Nordisk A/S

INDUSTRY